The Digital Neurotherapeutics Market is expected to register a CAGR of 19.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Component (Software, Hardware, Services). The market is further segmented based on Indication (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Other Indications). Also, the market is further segmented based on End User (Patients, Providers, Payers, Other End Users). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Digital Neurotherapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Digital Neurotherapeutics Market Segmentation
Component- Software
- Hardware
- Services
- AlzheimerÂ’s Disease
- ParkinsonÂ’s Disease
- Multiple Sclerosis
- Epilepsy
- Other Indications
- Patients
- Providers
- Payers
- Other End Users
Strategic Insights
Digital Neurotherapeutics Market Growth Drivers- Increase in Neurological Disorder 2 Growth: Rising global incidences of neurological disorders like epilepsy, Parkin's disease, and depression have contributed to the growth of the digital neurotherapeutics market. Digital neurotherapeutics are available with novel methods for symptom management and have better outcomes in such patients as many of them do not respond to conventional treatments. This fact has indeed engendered the market to grow.
- Most Interesting Increasing Digitization of Health Solutions: Increased digitization has become apparent with applications in mobile and wearable gadgets as well as remote monitoring tools, and this is all aiding the cause of digital neurotherapy. Real-time tailoring of treatment provides a patient but also the ultimate provider-with potential better alternatives than comparative therapies could offer. Many opportunities closer to mainstream health care are what draw in digital neurotherapeutic methods.
- Cost- and Easy Treatment: Digital neurotherapeutics are a real superpower in getting some of the most effective and inexpensive access to care-for traditional therapy, without offering it automatically-but especially into such positions that patients and health care systems might find appealing about such therapies. Digital therapeutics will probably introduce into various settings altogether lowered health care costs for more affordability of at-home management of neurological disorders while becoming more accessible and less expensive at a time when a huge demand for affordable care is growing.
- Integration of Mobile Health Platforms: These are mobile health platforms that will be integrated with treatment delivery of neurotherapeutics. There will be no such mobile health apps, wearables, and others capable of making a patient stay on taking anti-neurological therapy through mobile app remote treatment of their neurological condition.
- Personalized Treatment Plans: Personalization is what drives most of the movement in digital neurotherapeutics. All data-that comprise the patient's genetic and lifestyle data-may keep creating individualized treatment protocols that improve the accuracy of the treatment and its side effects while also empowering providers to personalize much better the health care of the neurology patient.
- Partnerships between Tech and Healthcare Providers: In fact, the establishment of partnerships between technology companies and healthcare providers continues to proliferate. It has increased the speed at which innovations in digital therapeutic solutions can be expedited because they are bolstered by clinical perspectives for technology innovation-all this resulting in improved patient compliance and seamless incorporation of digital therapy into existing healthcare systems-all of these acting as factors propelling market growth.
- Expansion Into Treating Mental Illness: Out of all forms of therapy for mental disorders-they being depression, anxiety, and PTSD-digital neurotherapeutics will prove to deliver the larges share of benefits. The market will surface with some access benefits for these digital therapy treatments that will serve a very much high-access approaches to meet mental health demand and increase their interoperability with noninvasive treatment approaches such as to serve as adjunct standard therapy. Further, as is said above, other means of addressing mental health would be growing in an area that would carry such a massive upside on marketing opportunities.
- Combining digital telehealth with physical practice: Telehealth has given rise to an intelligent prognosis for digital neurotherapeutics. Teleconsultation may be combined with digital intervention, causing the patient to have continuous and accessible comprehensive care for neurological disorders. Thus treatment is easy to reach, especially among persons who live in underserved geographical areas, as well as the growing drive toward efficiency and affordability that propels the digital neurotherapeutics market.
- Collaboration with Pharmaceutical Companies: Digital neurotherapeutics capacity for aggressive engagement with pharmaceutical companies is enormous. Drug development is increasingly incorporating, along with an extensive array of digital patient monitoring and adherence components, synergies between digital health players and medicines companies for new pathways for therapeutics. Partnerships of this kind will add to the digital neurotherapeutics portfolio, which might also involve the integration of care with traditional therapy, with resulting expansion of market opportunities.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Digital Neurotherapeutics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Digital Neurotherapeutics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?

Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Frequently Asked Questions
The digital neurotherapeutics market is estimated to witness a CAGR of 19.5% from 2025 to 2031
North America region accounted for the accounted for the highest market share
The report can be delivered in PDF/Word format, we can also share excel data sheet based on request.
Akili Inc., AdvancedMD Inc., AppliedVR Inc., BigHealth, and Blackrock Neurotech accounted for major market shares in the year 2024
Asia Pacific region is the fastest growing in the market
2021 to 2023- are the historic year, 2024 - base year, 2025 to 2031- are the forecast year
- Akili Inc.
- AdvancedMD Inc.
- AppliedVR Inc.
- BigHealth
- Blackrock Neurotech
- Cognivive Inc.
- Neofect Co. Ltd
- Omada Health Inc.
- Neurotherapeutic Pediatric Therapies Inc.
- Mindmaze
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.